Alexander Nowak
Stock Analyst at Lucid Capital
(3.34)
# 2,424
Out of 4,983 analysts
336
Total ratings
41.2%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XTNT Xtant Medical Holdings | Initiated Coverage: Buy | $1 | $0.32 | +212.50% | 1 | Sep 2, 2026 | |
| IMDX Insight Molecular Diagnostics | Initiated Coverage: Buy | $8 | $3.58 | +123.46% | 1 | Aug 24, 2026 | |
| COCH Envoy Medical | Initiated Coverage: Buy | $2 | $0.7101 | +181.65% | 1 | Jul 27, 2026 | |
| FOCL EDAP TMS | Initiated Coverage: Buy | $10 | $4.07 | +145.70% | 1 | Jun 22, 2026 | |
| HUT Hut 8 | Reiterated: Hold | $12 | $89.82 | n/a | 2 | Apr 1, 2024 | |
| CELC Celcuity | Rated: Buy | n/a | $82.58 | n/a | 16 | Mar 28, 2024 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $8 | $6.63 | n/a | 19 | Mar 20, 2024 | |
| INFU InfuSystem Holdings | Rated: Buy | n/a | $12.45 | n/a | 11 | Mar 15, 2024 | |
| KRMD KORU Medical Systems | Rated: Buy | n/a | $3.20 | n/a | 22 | Mar 14, 2024 | |
| PHAT Phathom Pharmaceuticals | Rated: Buy | n/a | $7.69 | n/a | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.32 | n/a | 11 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.53 | n/a | 21 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $53.55 | n/a | 28 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $345.34 | n/a | 27 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $174.90 | n/a | 15 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.95 | n/a | 4 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $18.94 | n/a | 17 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.77 | n/a | 27 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.41 | n/a | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $72.33 | n/a | 17 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.02 | n/a | 18 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $7.12 | n/a | 1 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.07 | n/a | 8 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.38 | n/a | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.73 | n/a | 1 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $23.93 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $275.20 | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $512.50 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.98 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $241.14 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8571 | n/a | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $172.91 | n/a | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $4 | $13.20 | n/a | 9 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.55 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $23.78 | n/a | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 | $1.34 | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.14 | n/a | 1 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $6.78 | n/a | 9 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $40 | $9.06 | n/a | 10 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $70.13 | n/a | 1 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $43.17 | n/a | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $32.00 | n/a | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $6.68 | n/a | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $5 | $0.1611 | n/a | 3 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $36 | $0.000001 | n/a | 8 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $211 | $513.62 | n/a | 1 | Feb 1, 2018 |
Xtant Medical Holdings
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $1
Current: $0.32
Upside: +212.50%
Insight Molecular Diagnostics
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.58
Upside: +123.46%
Envoy Medical
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.7101
Upside: +181.65%
EDAP TMS
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $4.07
Upside: +145.70%
Hut 8
Apr 1, 2024
Reiterated: Hold
Price Target: $12
Current: $89.82
Upside: n/a
Celcuity
Mar 28, 2024
Rated: Buy
Price Target: n/a
Current: $82.58
Upside: n/a
DiaMedica Therapeutics
Mar 20, 2024
Reiterated: Buy
Price Target: $8
Current: $6.63
Upside: n/a
InfuSystem Holdings
Mar 15, 2024
Rated: Buy
Price Target: n/a
Current: $12.45
Upside: n/a
KORU Medical Systems
Mar 14, 2024
Rated: Buy
Price Target: n/a
Current: $3.20
Upside: n/a
Phathom Pharmaceuticals
Mar 8, 2024
Rated: Buy
Price Target: n/a
Current: $7.69
Upside: n/a
Mar 5, 2024
Rated: Buy
Price Target: n/a
Current: $1.32
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $17.53
Upside: n/a
Feb 29, 2024
Reiterated: Hold
Price Target: n/a
Current: $53.55
Upside: n/a
Feb 29, 2024
Rated: Buy
Price Target: n/a
Current: $345.34
Upside: n/a
Feb 23, 2024
Rated: Buy
Price Target: n/a
Current: $174.90
Upside: n/a
Feb 22, 2024
Reiterated: Buy
Price Target: $20
Current: $1.95
Upside: n/a
Feb 21, 2024
Rated: Buy
Price Target: n/a
Current: $18.94
Upside: n/a
Feb 21, 2024
Downgraded: Hold
Price Target: n/a
Current: $10.77
Upside: n/a
Feb 15, 2024
Reiterated: Hold
Price Target: n/a
Current: $1.41
Upside: n/a
Feb 2, 2024
Rated: Buy
Price Target: $80
Current: $72.33
Upside: n/a
Jan 31, 2024
Rated: Buy
Price Target: n/a
Current: $3.02
Upside: n/a
Jan 29, 2024
Rated: Buy
Price Target: n/a
Current: $7.12
Upside: n/a
Jan 24, 2024
Rated: Buy
Price Target: n/a
Current: $3.07
Upside: n/a
Jan 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $35.38
Upside: n/a
Jan 2, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.73
Upside: n/a
Nov 2, 2023
Reiterated: Buy
Price Target: $40
Current: $23.93
Upside: n/a
Oct 11, 2023
Reiterated: Buy
Price Target: n/a
Current: $275.20
Upside: n/a
Oct 9, 2023
Rated: Buy
Price Target: n/a
Current: $512.50
Upside: n/a
Oct 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $3.98
Upside: n/a
Oct 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $241.14
Upside: n/a
Oct 3, 2023
Reiterated: Buy
Price Target: n/a
Current: $0.8571
Upside: n/a
Oct 2, 2023
Rated: Buy
Price Target: n/a
Current: $172.91
Upside: n/a
Jul 24, 2023
Reiterated: Hold
Price Target: $2 → $4
Current: $13.20
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: n/a
Current: $11.55
Upside: n/a
Jul 14, 2023
Rated: Buy
Price Target: n/a
Current: $23.78
Upside: n/a
Jul 13, 2023
Rated: Buy
Price Target: $60
Current: $1.34
Upside: n/a
May 26, 2023
Rated: Buy
Price Target: n/a
Current: $3.14
Upside: n/a
May 12, 2023
Rated: Buy
Price Target: $8
Current: $6.78
Upside: n/a
May 9, 2023
Rated: Sell
Price Target: $40
Current: $9.06
Upside: n/a
May 2, 2023
Rated: Buy
Price Target: n/a
Current: $70.13
Upside: n/a
Apr 19, 2023
Reiterated: Buy
Price Target: $28
Current: $43.17
Upside: n/a
Feb 14, 2023
Rated: Buy
Price Target: $58
Current: $32.00
Upside: n/a
Feb 9, 2023
Rated: Buy
Price Target: $3
Current: $6.68
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $10 → $5
Current: $0.1611
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $8 → $36
Current: $0.000001
Upside: n/a
Feb 1, 2018
Reiterated: Buy
Price Target: $211
Current: $513.62
Upside: n/a